Q1 FY27 Results: Revenue up 16% YoY at Rs 705 Cr, PAT at Rs 99 Cr
EPIGRAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.2 pts less than Nifty Microcap 250 and 1.7 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Epigral Limited reported Q1 FY27 revenue from operations at Rs 705.36 Cr, up 16.3% YoY from Rs 606.54 Cr. PBT grew 24.8% to Rs 133.18 Cr. PAT was Rs 99.18 Cr vs Rs 160.41 Cr in Q1 FY26, the YoY dip due to a one-time deferred tax credit of about Rs 80.87 Cr in the base quarter. Sequentially, PAT rose 21% from Rs 81.93 Cr. EPS at Rs 22.99. Auditors issued a clean review report.
Strong operational show with revenue and PBT growth. YoY PAT dip is from base-quarter one-time tax credit, not operations. Clean audit.